Healthcare artificial intelligence company Qure.ai has appointed Malika Shrivastava as its new Chief Marketing Officer (CMO), strengthening its leadership team as the company expands its global presence and accelerates the adoption of AI-powered healthcare solutions across international markets.
Shrivastava joins Qure.ai with more than two decades of experience in brand strategy, business growth and integrated marketing across technology and healthcare sectors. In her new role, she will lead the company's global marketing strategy, brand positioning, communications and demand generation efforts as Qure.ai continues to scale its AI-driven diagnostic solutions worldwide.
The appointment comes at a time when Qure.ai is witnessing increased adoption of artificial intelligence in medical imaging, with healthcare providers increasingly deploying AI tools to improve disease detection, streamline clinical workflows and expand access to diagnostic services. The company said strengthening its marketing leadership aligns with its next phase of international growth and customer engagement.
Before joining Qure.ai, Shrivastava held senior marketing leadership positions across multinational organisations, where she led integrated marketing strategies, digital transformation initiatives and brand-building programmes. Her experience spans enterprise technology, healthcare innovation and business-to-business marketing, equipping her to lead Qure.ai's global marketing function as the company expands across developed and emerging healthcare markets.
Qure.ai develops AI-powered solutions that assist healthcare professionals in detecting diseases from medical imaging, including chest X-rays, CT scans and ultrasound images. Its products are used in the diagnosis and management of conditions such as tuberculosis, lung cancer, stroke and traumatic brain injuries. The company operates in more than 100 countries and collaborates with hospitals, diagnostic centres, governments and healthcare organisations to improve access to timely diagnosis.
The company's AI technologies are designed to support radiologists and clinicians by automating image analysis, prioritising critical cases and reducing reporting turnaround times. As demand for AI-assisted healthcare continues to rise, Qure.ai has increasingly focused on expanding partnerships with public health agencies and healthcare providers to improve early disease detection and clinical efficiency.
Commenting on the appointment, Prashant Warier, Co-founder and Chief Executive Officer of Qure.ai, said the company is entering a new stage of growth where brand leadership will play an increasingly important role in expanding its global reach. He noted that Shrivastava's experience in building high-growth brands and executing strategic marketing initiatives would help strengthen Qure.ai's position in the healthcare AI market.
Shrivastava said she looks forward to contributing to Qure.ai's mission of making healthcare more accessible through artificial intelligence. She noted that the company has established a strong reputation in AI-powered diagnostics and expressed interest in helping amplify its impact among healthcare providers, policymakers and industry stakeholders worldwide.
The appointment reflects a broader trend across the healthcare technology sector, where companies are strengthening leadership teams to support international expansion and commercial growth. As AI applications move beyond pilot deployments into mainstream clinical practice, organisations are increasingly investing in brand development, customer education and market engagement alongside product innovation.
Industry analysts expect healthcare AI to remain one of the fastest-growing enterprise AI segments over the coming years, driven by increasing demand for early disease detection, improved diagnostic accuracy and workflow automation. Companies operating in this space are also expanding their commercial teams to address growing opportunities across hospitals, public health programmes and diagnostic networks.
With Shrivastava joining the executive leadership team, Qure.ai is expected to further strengthen its marketing strategy as it continues expanding its footprint across global healthcare markets. The appointment underscores the company's focus on combining AI innovation with stronger brand visibility to support the wider adoption of intelligent diagnostic technologies.